ECSP099396A - Nuevos derivados azabicíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen - Google Patents

Nuevos derivados azabicíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen

Info

Publication number
ECSP099396A
ECSP099396A EC2009009396A ECSP099396A ECSP099396A EC SP099396 A ECSP099396 A EC SP099396A EC 2009009396 A EC2009009396 A EC 2009009396A EC SP099396 A ECSP099396 A EC SP099396A EC SP099396 A ECSP099396 A EC SP099396A
Authority
EC
Ecuador
Prior art keywords
azabycyclic
derivatives
new
pharmaceutical compositions
compositions containing
Prior art date
Application number
EC2009009396A
Other languages
English (en)
Inventor
Pierre Lestage
Patrick Casara
Anne-Marie Chollet
Alain Dhainaut
Fany Panayi
Anita Roger
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of ECSP099396A publication Critical patent/ECSP099396A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Compuestos de fórmula (I) : en la que :o ALK representa una cadena alquileno,o W representa un grupo elegido entre en el que R y R' son tales como se han definido en la descripción.Medicamento.
EC2009009396A 2008-06-13 2009-06-09 Nuevos derivados azabicíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen ECSP099396A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0803297A FR2932479A1 (fr) 2008-06-13 2008-06-13 Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ECSP099396A true ECSP099396A (es) 2010-01-29

Family

ID=40227963

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009396A ECSP099396A (es) 2008-06-13 2009-06-09 Nuevos derivados azabicíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen

Country Status (29)

Country Link
US (1) US7906547B2 (es)
EP (1) EP2133333A1 (es)
JP (1) JP2009298790A (es)
KR (1) KR20090129958A (es)
CN (1) CN101602706A (es)
AP (1) AP2009004891A0 (es)
AR (1) AR072101A1 (es)
AU (1) AU2009202341A1 (es)
BR (1) BRPI0902395A2 (es)
CA (1) CA2668527A1 (es)
CL (1) CL2009001377A1 (es)
CO (1) CO6190096A1 (es)
CR (1) CR10844A (es)
EA (1) EA200900692A1 (es)
EC (1) ECSP099396A (es)
FR (1) FR2932479A1 (es)
GT (1) GT200900150A (es)
MA (1) MA31141B1 (es)
MX (1) MX2009005891A (es)
MY (1) MY144748A (es)
NI (1) NI200900114A (es)
NZ (1) NZ577438A (es)
PE (1) PE20091961A1 (es)
SG (1) SG158015A1 (es)
SV (1) SV2009003292A (es)
TW (1) TW201000101A (es)
UY (1) UY31857A1 (es)
WO (1) WO2009150331A1 (es)
ZA (1) ZA200903939B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10892398B2 (en) * 2019-03-28 2021-01-12 Johannes Pollanen Qubit hardware for electrons on helium
EP4251148A1 (en) 2020-11-27 2023-10-04 Richter Gedeon Nyrt. Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515013B2 (en) * 2000-07-13 2003-02-04 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
US7232835B2 (en) * 2002-12-10 2007-06-19 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1707203A1 (en) * 2005-04-01 2006-10-04 Bioprojet Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands
DK1869019T3 (da) * 2005-04-08 2014-10-06 Pfizer Prod Inc Bicycliske [3.1.0]heteroarylamider som glycintransportinhibitorer type I
EP1842846A1 (en) * 2006-04-07 2007-10-10 Santhera Pharmaceuticals (Schweiz) AG Phenylpiperidine derivatives as melanocortin-4 receptor modulators
AU2007274598A1 (en) * 2006-07-21 2008-01-24 Lupin Limited Antidiabetic azabicyclo [3. 1. 0] hexan compounds

Also Published As

Publication number Publication date
BRPI0902395A2 (pt) 2010-04-20
WO2009150331A1 (fr) 2009-12-17
EA200900692A1 (ru) 2009-12-30
MY144748A (en) 2011-10-31
CR10844A (es) 2009-07-23
KR20090129958A (ko) 2009-12-17
US7906547B2 (en) 2011-03-15
CO6190096A1 (es) 2010-08-19
FR2932479A1 (fr) 2009-12-18
SG158015A1 (en) 2010-01-29
TW201000101A (en) 2010-01-01
PE20091961A1 (es) 2010-01-23
AR072101A1 (es) 2010-08-04
CL2009001377A1 (es) 2010-05-28
UY31857A1 (es) 2009-08-31
GT200900150A (es) 2011-08-25
CN101602706A (zh) 2009-12-16
MX2009005891A (es) 2010-02-17
AP2009004891A0 (en) 2009-06-30
SV2009003292A (es) 2010-02-01
AU2009202341A1 (en) 2010-01-07
ZA200903939B (en) 2010-04-28
MA31141B1 (fr) 2010-02-01
CA2668527A1 (fr) 2009-12-13
US20090312389A1 (en) 2009-12-17
NZ577438A (en) 2010-09-30
NI200900114A (es) 2010-02-03
EP2133333A1 (fr) 2009-12-16
JP2009298790A (ja) 2009-12-24

Similar Documents

Publication Publication Date Title
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
GT200600518A (es) Derivados de pirimidina
CR11819A (es) Compuestos de isoindolina 5-sustituidos
EA201170772A1 (ru) Органические соединения
UY28572A1 (es) Compuestos novedosos
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
NI200900147A (es) Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
ECSP099216A (es) Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
DOP2008000089A (es) 18-metil-19-nor-androst-4-en-17, 17-espiroeteres (18-metil-19-nor-20-espirox-4-en-3-onas), asi como preparaciones farmaceuticas que los contienen
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
UY29804A1 (es) Quinolinas de alquilnitrilo
UY33073A (es) Nuevos derivados del tipo hexahidrociclopenta [ b]pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
ECSP099396A (es) Nuevos derivados azabicíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR061740A1 (es) Nuevos derivados naftalenicos, su procedimiento de praparacion y las composiciones farmaceuticas que los contienen
ECSP12011950A (es) Nuevos derivados de azabiciclo[3.1.0]hex-2-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20090105A7 (es) Nuevos derivados azabicíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
ECSP10010649A (es) Nuevos derivados de azabiciclo[3.2.0]hept-3-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY33074A (es) Nuevos derivados de azabiciclo[3.2.0]hept-6-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20130037A7 (es) Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY28387A1 (es) Compuestos novedosos
CR9115A (es) Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
ECSP10010292A (es) Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen